Opening new perspectives in ophthalmology research through digital innovations

Ophthalmology is undergoing a digital transformation, as modern eye care studies increasingly integrate imaging, wearables, and real-world endpoints to improve the patient journey.

Let's create an impact. Together.

The Future of Ophthalmic Research

Alcedis supports ophthalmic research with tailored study services and system-integrated workflows. We help sponsors with the perfect combination of comprehensive services and innovative technical solutions as a full-service CRO.

Digitizing Clinical Trials for Ophthalmic Research

The shift to decentralized and hybrid trial designs enables better collection, analysis and management of data and leads to improved patient experience through the use of wearables and patient apps. 

Increased Activity

Tracking the physical activity offers insights into disease burden and progression, e.g. daily steps are associated with symptom-severity​.

Digitized Vision Tests

Digitial Visual acuity tests through smartphones/tablets offer specificity and sensitivy comparable to clinical tests without compromising quality.

Patient Engagement

Frequent usage of quality of life ePROs (e.g. EQ-5D) in randomized trials as primary and secondary endpoints drives patient engagement and retention.

Trust in our Experience 

  • We combine thought leadership with operational excellence focused on scientific results rather than box-ticking.
  • Bringing a high level of academic engagement to deliver the full suite of trial related services, unlike any traditional contract model.  

 

Contact Experts

Suitable Technologies 

With our strong technological expertise, we are setting new standards in ophthalmic research with our integrated, patient-centered and data-driven platform. 

Discover Technologies

Let's create an impact. Together.

With our comprehensive approach that combines technological innovation and a deep understanding of clinical research, we are ideally positioned to successfully conduct digital clinical trials in the field of ophthalmic research.

Contact us